$ 0.7500 <%= Resources.Global.txtUp %>
Updated 17/07/2018
Change % 2.04% Stock price increasing
Change 0.015 Stock price increasing
Volume 25,496
High $ 0.7630
Low $ 0.7350
Open $ 0.7350
Prev close $ 0.7350
# of shares 106.05M
Market cap 79.54M USD

Market closed
Vivus Inc
Market is closed, opens at 14:30
Price development Latest 1 week 1 month 3 months 6 months 1 year
  0.75 -3.8% Stock price decreasing -9.6% Stock price decreasing 77.4% Stock price increasing 58.9% Stock price increasing -39.0% Stock price decreasing
Powered by TradingView

Company profile

VIVUS Inc is a US-based biopharmaceutical company which is engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. The company's commercial products include Qsymia is an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index and Stendra/Spedra, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. The company operates through the single segment of business being Development and commercialization of novel therapeutic products.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
18 July 2018 06:05:18
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180712.1 - EUROWEB4 - 2018-07-18 07:05:18 - 2018-07-18 06:05:18 - 1000 - Website: OKAY